Skip to content
Head to head

The Chemours vs Linde

Side-by-side on the measures that matter, with a plain-English read. Full detail: CC · LIN

Updated 2 minutes ago

1-year performance, rebased to 100

CC +12.5%LIN +27.0%
Linde edges it on the scoreable measures. Linde has the highest Quant Rating (69); Linde has done best over the past year (+25%); Linde earns the most per share.
CCLIN
Snapshot
SectorSpecialty ChemicalsSpecialty Chemicals
Last price10.88502.83
Change today-7.80%-1.45%
1-year return+6.5%+24.8%
Market cap$1.64B$230.84B
52-week range10.77 – 28.22384.00 – 546.40
Valuation
P/E (TTM)-10.6733.39
P/E percentile, own 5-yr range14th57th
P/B10.565.86
Dividend yield3.22%1.25%
Profitability & growth
EPS (TTM)-2.5714.61
Net profit (TTM)$-386.87M$6.71B
Revenue (TTM)$5.84B$36.24B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+3.0%+9.2%
Gross margin15.1%47.9%
Operating margin0.8%27.1%
Net margin-2.6%19.3%
Free cash flow (TTM)$211.00M$5.08B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership88.0%88.6%
Insider activity (12mo)33 buy / 16 sell27 buy / 16 sell
Short interest (% of float)9.7%1.4%
Analyst consensus33% buy / 67% hold (9)94% buy / 6% hold (16)
Analyst price target$17 (+55%)$570 (+13%)
StockVane view
StockVane Quant RatingD (63)C (69)
Company
Employees5,70065,177
Founded20142017

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.